| James Robert Mason, ACMHC | |
|
50 N 200 E, Lehi, UT 84043-1812 | |
| (800) 817-1899 | |
| (800) 817-1899 |
| Full Name | James Robert Mason |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 50 N 200 E, Lehi, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134734569 | NPI | - | NPPES |
| 1134734569 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| James Robert Mason, ACMHC 50 N 200 E, Lehi, UT 84043-1812 Ph: (800) 817-1899 | James Robert Mason, ACMHC 50 N 200 E, Lehi, UT 84043-1812 Ph: (800) 817-1899 |
News Archive
GE Healthcare and Vanderbilt University Medical Center today announced a five-year partnership to enable safer and more precise cancer immunotherapies. Multiple diagnostic tools will be developed to help predict both the efficacy of an immunotherapy treatment and its adverse effects for a specific patient before the therapy is administered.
Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.
Pinnacle Biologics, Inc., a subsidiary of Concordia Healthcare Corp., announced today the initiation of the pivotal Phase 3 trial (OPUS) in Germany for a rare form of bile duct cancer for which there is currently no acceptable therapy.
Haemacure Corporation announces that it has today received notice from the Toronto Stock Exchange that its shares will be delisted from the TSX at the close of the market on February 5, 2010.
Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that "for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option."
› Verified 3 days ago
Rosalie Dirado, Counselor Medicare: Not Enrolled in Medicare Practice Location: 50 N 200 E Ste A, Lehi, UT 84043 Phone: 801-766-3933 | |
Jeffrey Stewart, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 N Thanksgiving Way, Lehi, UT 84043 Phone: 801-885-9595 | |
Whitney Evans, ACMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 3051 W Maple Loop Dr Ste 202, Lehi, UT 84043 Phone: 385-254-3522 | |
James Leblow, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 North Thanksgiving Way, Lehi, UT 84043 Phone: 013-106-8808 | |
Norma Farris, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3051 W Maple Loop Dr Ste 210, Lehi, UT 84043 Phone: 801-872-5516 Fax: 801-880-0069 | |
Eden Clegg, Counselor Medicare: Not Enrolled in Medicare Practice Location: 4735 N Thanksgiving Way, Lehi, UT 84043 Phone: 801-310-6880 | |
Jeffrey Yee, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3051 W Maple Loop Dr Ste 300, Lehi, UT 84043 Phone: 385-336-4740 |